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Abstract 
We have analyzed the expression of the DNA repair genes 06-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine- 
DNA glycosylase (MPG) at RNA and protein activity level in primary rat hepatocytes in vitro and various rat hepatoma cell lines 
exhibiting different status of differentiation. The basal level of MGMT mRNA and activity correlated well with the degree of 
differentiation, as measured by tyrosine aminotransferase (TAT) mRNA expression. Induction of MGMT mRNA and protein activity by 
X-ray and N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) treatment was most pronounced in the well-differentiated hepatocytes and in 
various differentiated hepatoma cell lines (up to 6-fold). There was virtually no induction in H5 hepatoma cells which exhibited the 
lowest degree of differentiation and expressed only low amounts of MGMT. For the other hepatoma cell lines tested, MGMT induction 
did not clearly correlate with TAT expression. Thus, Fao cells which exhibited a high degree of differentiation responded only very 
weakly with respect to induction. The results indicate that the basal level of MGMT mRNA expression is dependent on liver-specific 
regulatory factors, whereas the inducibility is a more complex phenomenon not solely dependent on them. Contrary to MGMT, MPG was 
constitutively expressed at relatively high amounts in all cell lines tested and no correlation was apparent with the degree of 
differentiation. MPG activity was significantly induced by mutagen treatment only in H4IIE cells. The tumor promoter phenobarbital 
induced MGMT, but not MPG mRNA in hepatocytes. The results indicate that MGMT and MPG are not co-regulated. Hepatoma cells 
with low MGMT level were most sensitive to MNNG-induced cytotoxicity. On the other hand, no correlation was apparent between MPG 
activity and sensitivity of the cell lines to methylating agents indicating that the MPG level is not predictive for alkylating drug resistance. 
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1. Introduction 
Damage induced in DNA by monofunctional alkylating 
agents is repaired in two ways. (i) Alkylations at the 
06-position of guanine are removed by the ubiquitous 
DNA repair protein, 06-methylguanine-DNA methyltrans- 
ferase (MGMT), which transfers the alkyl group to its own 
active center leading to restoration of guanine in DNA and 
Abbreviations: MNNG, N-methyl-N’-nitro-N-nitrosoguanidine; MMS, 
methyl methanesulfonate; PB, phenobarbital; IF, induction factor; MGMT, 
06-methylguanine-DNA methyltransferase; MPG, N-metbylpurine-DNA 
glycosylase; TAT, tyrosine aminotransferase; GAPDH, glyceraldehyde 
phosphodehydrogenase. 
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functional inactivation of the repair protein (for review, see 
Ref. [l]). (ii) Various other alkylated bases, such as 3- 
methyladenine and 7-methylguanine, are removed from 
DNA via the excision repair pathway, the first step of 
which is catalyzed by the N-methylpurine-DNA glycosy- 
lase (MPG). This repair enzyme removes N-methylpurines 
by hydrolysis of the N-glycosylic bond that links the base 
to the DNA backbone leaving an apurinic site in DNA 
which is finally repaired by excision of the apurinic site 
containing segment and filling in of the resulting gap by 
repair synthesis and religation [2,3]. 
In bacteria both repair activities can be induced upon 
alkylation giving rise to resistance of cells to the muta- 
genic and killing effect of alkylating agents [4]. For mam- 
malian cells a bulk of data is available showing that the 
MGMT repair activity and the amount of MGMT mRNA 
0925-4439/95/$09.50 0 1995 Elsevier Science B.V. All rights reserved 
SSDlO925-4439(94)00073-5 
64 T. Grombacher, B. Kaina / Biochimica et Biophysics Acta 1270 (1995) 63-72 
is enhanced upon ionizing radiation, exposure to alkylating 
agents and other DNA damaging treatments [5-111. For 
MPG it is far less clear whether it is inducible on RNA or 
protein level [9,12]. 
Induction of MGMT in rat hepatoma cells by MNNG or 
X-rays gives rise to protection of cells against the muta- 
genic effect of a challenge dose of MNNG [8]. Induction 
was also found to protect the cells against the toxic effect 
of bis-chloroethylnitrosourea [13] and to reduce the fre- 
quency of neoplastic transformation in vitro [14]. Further- 
more, overexpression of MGMT in transgenic cell lines 
and in mice exerted protection against methylating agents 
such as MNNG and N-methyl-N-nitrosourea to all end 
points studied so far, including cytogenetic effects, toxic- 
ity, gene mutations and tumorigenicity [15-B]. 
Since MGMT efficiently protects cells against the cyto- 
toxic effect of chemotherapeutic chloroethylating drugs 
and thus may affect the effectiveness of cancer treatment 
[19], the constitutive and inducible expression of this repair 
protein in various organs deserves attention. MGMT was 
found to be induced most reproducibly and at relatively 
high levels in rat hepatoma cells in vitro and in the rat 
liver (reviewed in Refs. [1,12]), raising the question whether 
MGMT induction is a liver-specific phenomenon depen- 
dent on the status of differentiation of the cells. To address 
this question, we have analyzed the amount of MGMT at 
the level of RNA and protein activity in various rat 
hepatoma cell lines that differ with respect to the degree of 
differentiation and in primary hepatocytes, upon treatment 
with X-rays or an alkylating agent (MNNG). Furthermore, 
we were interested to see whether or not MPG is expressed 
in a similar fashion as MGMT. Our results indicate that the 
constitutive expression of MGMT mRNA and protein, but 
not that of MPG, is related to the status of differentiation 
of rat liver cells. The induction by mutagen treatment of 
MGMT mRNA and protein was most marked in the 
differentiated cell lines and in primary hepatocytes, but 
there was no clear-cut relation to the status of differentia- 
tion, indicating that complex regulatory mechanisms are 
involved in MGMT induction. 
2. Materials and methods 
2.1. Cell culture 
The rat hepatoma cell lines H5, H4IIEC3/T, 
H411EC3/Gm and Fao were obtained from F.J. Wiebel 
(GSF, Munich, Germany) and have been described previ- 
ously [20]. The H4IIE cell line was delivered from K.-L. 
Lee (Oak Ridge National Laboratories, USA). These cells 
have been used in previously reported studies [8]. All cell 
lines, except H4IIE, were cultivated in F12/Dulbecco’s 
medium (1:l) containing 10% fetal calf serum (Gibco). 
The H4IIE cells were cultivated in alpha modified Eagle’s 
medium containing 5% fetal calf serum and antibiotics (50 
pg/ml gentamycin). 
2.2. Animals 
Male Sprague-Dawley CD rats weighing 150 g were 
obtained from Charles River (Germany). The animals were 
acclimatised for a period of 1 week in a 12 h dark-light- 
rhythm and fed ad libidum. The animals were starved 24 h 
before liver perfusion. 
2.3. Liver perfusion and culture of hepatocytes 
Liver perfusion was performed by a two-step collage- 
nase perfusion protocol as described [21]. In brief, the 
isolated liver was first perfused by a calcium and magne- 
sium free medium to disrupt the cell-cell connections and 
then with collagenase solution to disrupt the extracellular 
matrix. For protection, the solution contained trypsin in- 
hibitor and DNase. The cells were then washed out of the 
liver. To enrich vital hepatocytes, the cells were subjected 
to Percoll (Pharmacia) density gradient centrifugation. The 
vital hepatocytes gathered at the bottom of the gradient, 
whereas non-hepatocytes formed a layer at the top of the 
Percoll solution. The viability of the hepatocytes was 
> 90% which was measured by trypan blue exclusion. For 
aggregation to spheroids, 2.5 . lo6 hepatocytes were culti- 
vated using Weymouth medium (Gibco) containing 10% 
CPSR-1 (Sigma) for 48 h on uncoated 10 cm-dishes (10 
ml each), with a medium change 24 h after seeding. 48 h 
after cultivation, hepatocytes which had aggregated to 
spheroids were transferred into Spinner-cell culture bottles 
for further cultivation [22]. 
2.4. Drugs and cell treatment 
MNNG and phenobarbital were obtained from Sigma. 
MNNG was dissolved in a small amount (approx. 200 ~1) 
of dimethylsulphoxide, diluted in distilled water and stored 
in aliquots at -80°C. MNNG from the stock solution (10 
mM) was added to the medium of exponentially growing 
cells or to the hepatocyte spheroid cultures (final concen- 
tration of 15 PM). Phenobarbital was dissolved prior to 
use in 100 mM NaOH and diluted in 30 ml medium which 
was then neutralized by 100 mM HCl. The final concentra- 
tion of the drug was 1.5 mM. X-ray irradiation was 
performed with exponentially growing hepatoma cells that 
were attached to the culture dishes. For irradiation of the 
hepatocytes, they were collected in 50 ml plastic tubes and 
then the medium was aspirated to give a final volume of 
10 ml. Immediately after irradiation fresh medium was 
added to the cells. They were harvested 24 h and 48 h after 
irradiation for RNA and protein assays, respectively. 
2.5. Plasmids 
pAPDG 10 containing the rat MPG cDNA and pcD- 
NAII containing the rat MGMT cDNA were kind gifts 
from Drs. F. Lava1 and T.R. O’Conner (Paris). For hy- 
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bridization, the MPG and MGMT cDNA inserts were 
excised from the plasmids and purified by gel elec- 
trophoresis. 
2.6. RNA extraction and Northern blot hybridization 
Total RNA was prepared by the guanidinium-isothio- 
cyanate-phenol-chloroform method [23]. 20-50 pg of total 
RNA was denatured in formaldehyde buffer and separated 
on a 1% agarose gel without the inclusion of formalde- 
hyde. The RNA was visualized by ethidium bromide and 
transferred onto a Gene Screene Plus (NEN, DuPont) or 
Hybond N+ (Arnersham) nylon membrane in 20 X SSC 
solution Ill]. 
2.7. Hybridization 
cDNA probes of MGMT and MPG were labeled using 
the random priming procedure according to the manufac- 
turer’s protocol (Stratagene) yielding a specific activity of 
5. 108-lo9 cpm/pg. Hybridization was performed at 
60°C in 1 M NaCl, 1% SDS, 10% dextran sulfate contain- 
ing 100 pg/ml denaturated salmon sperm DNA. For 
washing, decreasing concentrations (1 X and 0.5 X > of 
SSC and 0.5% SDS were used at 60°C. The wet filters 
were wrapped in sealable plastic bags and exposed to 
X-ray films. For rehybridization, the filters were stripped 
by incubating in 1% SDS at 80°C for 0.5 h. The filters 
were washed in 2 X SSC and resealed wet. The amounts of 
mRNA hybridized onto the filter were quantified by den- 
sitometric scanning of the films. Differences in loading 
were normalized by the amount of GAPDH mRNA in the 
same sample. Induction factors were calculated in relation 
to GAPDH mRNA, which were not found to be affected 
by the treatments applied [ll]. 
2.8. Protein isolation 
Total protein was prepared from exponentially growing 
cells. During the preparation the protein extract was kept 
on ice and all solutions were cooled prior to use. Cells 
were washed twice with PBS and collected by centrifuga- 
tion (1200 ‘pm, 4 min). Cells were disrupted by sonication 
in 70 mM Tris (pH 8), 1 mM EDTA, 5% glycerol and the 
cell debris removed by centrifugation. The supematant was 
aliquoted and immediately frozen in liquid nitrogen. The 
protein content in the supematant was determined by the 
Bradford dye-binding assay (Bio-Rad). 
2.9. MGMT activity 
MGMT activity was determined by the transfer of 
3H-labeled 06-methylguanine from a DNA template to 
protein. The DNA was from salmon sperm (Sigma) and 
labeled with [ ‘HImethyl-N-nitrosourea (16 Ci/mmol, 
Amersham) as described [15]. In a standard reaction 200 
pg of cell extract protein was incubated at 37°C with 
3H-labelled DNA (120000 cpm) in 70 mM Hepes, 1 mM 
D’IT, 5 mM EDTA, pH 7.8. After 30 min the reaction was 
stopped by the addition of 11 ~1 trichloroacetic acid and 
the DNA hydrolyzed by incubating for 15 min at 100°C. 
The precipitated protein was collected by centrifugation 
and washed three times with 5% TCA. Finally the protein 
was solubilized in 0.1 N NaOH by heating and the radioac- 
tivity determined in a liquid scintillation counter. The 
MGMT activity was calculated as fmol of [3H]methyl 
transferred to TCA-insoluble material per mg total cell 
extract protein. Since cells of the lines studied differ 
considerably in size, the repair activity was recalculated 
for a given number of cells. For this purpose the protein 
content of the cells was determined. It amounted to 80 
pug/lo6 H5 cells, 210 pg/106 H4IIE cells, 180 pg/106 
H4IIEC3/T cells, 300 pg/106 H4IIEC3/G‘ cells, 240 
pg/106 Fao cells, and 3430 pg/106 hepatocytes. MGMT 
activity was expressed as fmol/106 cells. As a control 
included in each assay served boiled extracts of Mex- 
HeLa MR cells or bovine serum albumine. The measured 
control level of radioactivity (approx. 120 cpm per 200 ,og 
protein) was subtracted from the activities detected in the 
liver cell extracts. 
2.10. MPG activity 
MPG activity was determined by the release of 3H- 
labelled 3-methyladenine and 7-methylguanine from alky- 
lated DNA template. The DNA substrate was salmon 
sperm DNA that was treated with [3H]dimethylsulfate 
(DuPont de Nemours, Bad Homburg; 1.1 Ci/mmol; 5 mCi 
for 20 mg DNA in 10 ml of 10 mM Tris, 1 mM EDTA, 
pH 7.5 for 12 h at room temperature; specific activity of 
the DNA: 0.541 &i/mg). Spontaneously hydrolyzed 
methylated bases were removed from the template DNA 
prior to use by column chromatography through Sephadex 
G-75. In a standard reaction, 300 pg of cell extract protein 
was incubated at 37°C with 3H-labelled DNA (60000 
cpm) in 100 mM KCl, 50 mM Hepes (pH 6.7) and 5 mM 
DTT. After 1 h, the reaction was stopped by cooling on 
ice. The DNA substrate was precipitated by the addition of 
50 pg salmon sperm DNA, 0.1 vol. 3 M sodium acetate 
and 2 vol. ethanol and collected by centrifugation. The 
supematant containing the released bases was dried in a 
speedvac and the pellet was dissolved in 4Clpl FPLC-run- 
ning buffer (0.4 M NH,H,PO,, 5% methanol). The 3H- 
labelled methylated bases were separated by reverse phase 
FPLC through a PepRPC HR5/5 column (Pharmacia) in 
FPLC running buffer. The flow rate was 0.5 ml per min. 
Prior to chromatography, 10 ~1 of a mixture of methylated 
purines (3-methyladenine, 1-methyladenine, l-methyl- 
guanine, cl-methylguanine; 1 mg/ml each) was added. The 
elution of the purines ,was followed up by UV spectropho- 
tometry. The fractions (0.5 ml each) containing the meth- 
ylated bases were measured for their 3H content. MPG 
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activity was determined as fmol of methylated bases (3- 
methyladenine and 7-methylguanine) that were released 
per mg of total protein per hour and expressed, taking into 
account the different protein content of the cell types (see 
MGMT assay), as fmol per lo6 cells per hour. 
2.11. Survival assays 
300 to 600 cells from exponentially growing cultures 
were seeded per 6-cm dishes and treated 6 h later with 
MNNG or MMS by adding the chemicals from a stock 
solution directly to the dishes. 1 h after adding the muta- 
gen, the medium was removed and new medium was 
added. Colonies were fixed 7-14 days after seeding, de- 
pending on the growth of the cells, with methanol and 
stained with crystal violet. Survival frequency was ex- 
pressed as the number of colonies on the treated plates 
divided by the number of colonies that appeared on the 
control dishes. The plating efficiency for H5 cells was 
approx. 50%, for H4IIEC3/T cells approx. 40%, for 
H411EC3/Ge cells approx. 25% and for Fao cells approx. 
65%. 
3. Results 
3.1. Basal level of expression of MGMT and MPG in rat 
hepatoma cell lines and hepatocytes 
The rat hepatoma cell lines we have chosen for our 
studies (H5, H4IIE, H4IIEC3/T, H4IIEC3/G; Fao) have 
been reported to differ significantly in their status of 
MGMT 
GAPDH 
TAT 
differentiation, as measured by the expression of aldrin 
epoxidase which is a liver-specific cytochrome P-450 
function, and other markers [20,24-261. Furthermore, the 
rat hepatocytes freshly isolated and maintained in culture 
as spheroids were previously shown to maintain a highly 
differentiated status in that they express cytochrome P-450 
mono-oxygenase over the entire cultivation period assayed, 
i.e., up to 1 week [22]. In our experiments, we have used, 
as an indicator of liver-specific differentiation, the expres- 
sion of TAT which is considered to be a liver-specific 
marker [27]. 
As shown in Fig. 1 (and Table 1 for quantification) the 
H5 line does not significantly express TAT mRNA. Also 
the aldrin epoxidase activity was not detectable in this cell 
line (Table 1). TAT is expressed, however, in increasing 
amounts in the lines H4IIEC3/T, H4IIE, H411EC3/GW 
and Fao. This agrees reasonably well with previous studies 
based on other liver-specific markers [20] and allows the 
conclusion that these cell lines are liver-specific ‘differen- 
tiated’ (Fao, H4IIEC3/G; H4IIE) or ‘dedifferentiated’ 
(H5, H4IIEC3/T). The highest level of TAT was found in 
the hepatocyte spheroid culture, which is in line with the 
high level of cytochrome P-450 mono-oxygenase ex- 
pressed under these culture conditions [22] indicating that 
the freshly isolated hepatocytes maintained their liver- 
specific status of differentiation for at least 1 week during 
which they were cultivated as spheroids in vitro. 
The basal activity of MGMT and MPG in the hepatoma 
cell lines and hepatocytes is shown in Table 1. H5 ex- 
pressed low, but significant amount of MGMT (4 fmol/106 
cells or 52 f 19 fmol/mg protein). An intermediary level 
of expression was found in H4IIEC3/T and H4IIE, and a 
MPG 
GAPDH 
Fig. 1. Expression of MGMT, MPG, and TAT mRNA in various untreated rat hepatoma cell lines and rat hepatocytes. 10 pg of total RNA was applied per 
slot. Northern blots for MGMT and MPG are from separate experiments (no reprobing). The membranes were re-hybridized with GAF’DH in order to 
correct for the amount of mRNA. 
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Table 1 
MGMT and MPG activity in rat hepatoma cell lines and primary rat hepatocytes not treated (basal level) or treated with MNNG or X-rays 
Cell type MGMT (fmoI/106 cells) 
basal level MNNG 
IF. 
MPG (fmoI[3MeA + 7MeG]/106 cells X h) TAT a AIdrin epoxidase b 
X-ray basal level MNNG X-ray 
IF. IF. IF. 
H5 4k2 0.4 0.1 4 0.9 65 + 3 60 0.9 90 1.3 b.d. 
H4IIE 113 + 23 196 1.7 176 1.6 74 f 14 251 3.4 224 3.0 0.116 
H4IIEC3/T 70 f 6 117 1.6 124 1.8 68 _t 22 110 1.6 100 1.3 0.05 
HQIIEC3/G- 204 f 47 183 0.9 199 1.0 178 + 39 279 1.6 236 1.3 0.229 
Fao 159 f 6 210 1.3 225 1.4 169 + 52 228 1.3 111 0.7 0.364 
Hepatocytes 192 + 164 1015 5.3 518 2.7 782 + 324 1252 1.6 1427 1.8 1.379 
b.d. 
0.8 
18.1 
29 
Freshly isolated hepatocytes were grown as spheroids. Cells were harvested for extract preparation 48 h after the addition of MNNG (15 PM) or X-ray 
irradiation (2 Gy). Each value represents the average of three independent determination. b.d., below level of detection; IF., induction factor. For 
comparison, the level of TAT mRNA expression and aldrin epoxidase enzyme activity is shown. 
a TAT expression is given in arbitrary units calculated from densitometric measurement of the amount of TAT mRNA and GAPDH mRNA (Fig. l), and is 
expressed in relation to GAPDH mRNA. 
b Data for aldrin epoxidase activity (pmoI/min per mg) are from Hesse et al. [20]. 
high level in Fao, H411EC3/Gm and hepatocytes. Thus, all 
cell types included in this study are phenotypically Mex+. 
The level of MPG activity present per cell did not correlate 
with MGMT activity. Thus, H5 cells expressed nearly as 
much MPG as H4IIE. An exceptional high amount of 
MPG activity was found in hepatocytes. 
In order to see whether the expression of MGMT and 
MPG is related to the extent of liver-specific differentia- 
tion, RNA was isolated from cell lines and from hepato- 
cytes, blotted and probed against MGMT, MPG, GAPDH 
(which served as an internal standard for the amount of 
RNA), and TAT. As shown in Fig. 1, H5 cells did not 
exhibit detectable amounts of MGMT mRNA. The consti- 
tutive MGMT mRNA level increased in the order 
H4IIEC3/T, H4IIE, H4IIEC3/G; Fao and primary hepa- 
tocytes. Overall, both MGMT and MPG mRNA paralleled 
the corresponding repair activity. An exception is provided 
by the hepatocytes whose high MPG activity was not 
reflected by a high amount of mRNA (in relation to 
GAPDH), as compared to the other cell types. 
The expression of MGMT and MPG mRNA as a func- 
tion of TAT is shown in Fig. 2. It is obvious that the 
amount of MGMT mRNA increases with TAT expression. 
This was not observed for MPG mRNA. Thus the constitu- 
tive level of MGMT, but not MPG mRNA appears to 
correlate with the status of differentiation. The data also 
indicate that the basal level of MPG and MGMT is not 
coordinately regulated in liver-derived cell lines and hepa- 
tocytes. 
3.2. Inducibility of MGMT 
The effect of X-ray and MNNG treatment on the level 
of MGMT mRNA in rat hepatoma cell lines and hepato- 
cytes is shown in Fig. 3. A significant induction of MGMT 
mRNA was observed for H4IIEC3/T cells (up to 6.5fold) 
and for the lines H4IIE and H411EC3/Ge (2- to 6-fold). 
Only a very weak response was found in Fao and none at 
all in H5 cells. Hepatocytes responded to treatment with 
X-rays with relatively strong induction of MGMT mRNA 
(5.3-fold) which is comparable to the level found in H4IIE 
cells. The level of induction of MGMT mRNA after X-ray 
and MNNG treatment in dependence of TAT expression is 
shown in Fig. 4. No correlation was found between MGMT 
mRNA induction and TAT expression. 
The induction of MGMT mRNA was accompanied by 
an increase in MGMT activity (Table 1). The strongest 
induction of MGMT repair activity was observed in hepa- 
tocytes (up to 5-fold with 15 ,uM of MNNG). It should be 
noted that, upon MNNG treatment, MGMT is depleted to 
some extent due to repair of the induced 06-methylguanine _ - 
possibly also by direct methylation. This might explain 
1.5 13 
1,4- - 
1*3- 
0 . 1.4 
1,2- 
1.1 - 
l,O- 
- 0,s 
- 0.2 
-0.1 
0.5 1 .o 
TAT expreeeion 
Fig. 2. Dependence of MGMT (0) and MPG (A ) mRNA expression on 
the level of TAT mRNA. The mRNA expression is given in arbitrary 
units, which are the quotient of MGMT/GAPDH, MPG/GAPDH and 
TAT/GAPDH, respectively. Data were obtained by densitometric scan- 
ning of the autoradiograms shown in Fig. 1. 
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* 
MGMT '_' 
GAPDH 
Fig. 3. Northern blot analysis of MGMT mRNA of rat hepatoma cell lines and hepatocytes treated with MNNG or X-rays. RNA was extracted 24 h after 
irradiation (2 Gy) or the addition of MNNG (15 PM) to the medium. The membrane was reprobed with GAPDH. The induction factor (1F) represents the 
relative amount of MGMT mRNA (MGMT/GAPDH) after treatment, in relation to the corresponding untreated control (C) that was included in each 
experiment. nd, not detectable. 
why the MNNG-treated H5 cells displayed significantly 
lower MGMT activity than the control. 
3.3. Inducibility of MPG 
The MPG mRNA levels 24 h after mutagen treatment in 
exposed and non-exposed liver cell lines and hepatocytes 
6 
1 
0 X-ray 
AMNNG 
A 
6- 
??
0 
are shown in Fig. 5. There was no significant induction of 
MPG mRNA. The MPG activity was measured 48 h after 
mutagen treatment and was found to be significantly en- 
hanced in H4IIE cells (3- and 3.4-fold for X-rays and 
MNNG, respectively). No or only very slight increase 
above the basal level was observed in the other cell lines. 
Rat hepatocytes showed only a weak (up to l.&fold) 
increase in MPG activity after X-ray and MNNG treatment 
(Table 1). Fig. 6 shows, for comparison, the magnitude of 
induction of MGMT and MPG activity in the liver cell 
lines and hepatocytes. It appears that MGMT and MPG 
activity is not coinduced upon treatment with X-rays and 
MNNG. 
4- A 
cl 
A 
2- 
??B 
,I- 
0 1 2 
TAT expression 
3.4. Effect of phenobarbital 
Phenobarbital is a potent tumor promoter in rat liver 
[28]. To see whether it is effective in inducing MGMT and 
MPG, rat hepatocytes were treated with the agent and the 
amount of MGMT and MPG mRNA was determined. In 
the same set of experiments treatment with MNNG was 
included. As shown in Fig. 7, both MNNG and phenobar- 
bital induced MGMT, but not MPG mRNA. 
3.5. Sensitivity of rat hepatoma cell lines to alkylating 
agents 
Fig. 4. Relation between MGMT and TAT expression in liver cells 
exposed to MNNG or X-rays. MGMT and TAT mRNA levels are given 
as arbitrary units (see Table 1 and Fig. 2). Data are from densitometric 
measurements of the autoradiograms shown in Fig. 3 and, for MNNG 
treated hepatocytes, Fig. 7. 
To analyze the cellular sensitivity to alkylating agents 
in relation to the expression of MGMT and MPG, the 
survival of rat hepatoma cells was determined after expo- 
sure to MNNG and MMS (Fig. 8). H5 cells, which dis- 
T. Grombacher, B. Kaina /Biochimica et Biophysics Acta 1270 (1995) 63-72 69 
Fig. 5. Northern blot analysis of MPG mRNA of rat hepatoma cell lines and hepatocytes treated with MNNG or X-rays. RNA was extracted 24 h after 
mutagen treatment (15 PM for MNNG, 2 Gy for X-rays). The membrane was re-hybridized with GAPDH. Induction factors (IF) were determined as 
described in Fig. 3. 
MGMT 
s 61 MN&G 
Fig. 6. Comparison of induction of MGMT and MPG protein activity by 
X-ray (2 Gy) or MNNG (15 PM) treatment. Induction factors are from 
data shown in Table 1, and are related to the basal activity of each cell 
type. 
played the lowest level of MGMT, were clearly more 
sensitive to MNNG than the other lines. These cells, 
however, were not more sensitive to MMS. An exceptional 
behavior showed Fao cells which were more resistant than 
the other cell lines to MMS. In the survival studies CHO-9 
cells were included for comparison. These cells do not 
express detectable amounts of MGMT and are comparable 
to H4 with respect to MPG activity (unpublished data). 
MGMT MPG 
GAPDH 
IF 
Fig. 7. Northern blot analysis of MGMT and MPG mRNA of rat 
hepatocytes treated with phenobarbital (1.5 mM) or MNNG (15 PM). C, 
untreated control. The RNA was extracted 24 h after drug exposure. The 
blots for MGMT and MPG are from separate experiments. They were 
reprobed with GAPDH. 
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CHO-9 cells are clearly hypersensitive to MNNG, but not 
to MMS. Thus, it appears that the sensitivity to MNNG is 
related to MGMT expression and that the MPG activity 
seems not to affect the resistance to MNNG and MMS. 
4. Discussion 
Whereas most DNA repair functions analyzed so far 
appear to be expressed more or less uniformly in various 
cell types, the expression of MGMT is highly variable, 
depending on the species, tissue and cell type, and in vitro 
growth characteristics (for review see Refs. [l] and [12]). 
MGMT is present at relatively high amount in the liver 
which is due to the high level of expression in hepatocytes. 
In non-parenchymal liver cells, only low amounts of 
MGMT have been found [29]. In addition to the high 
constitutive level, induction of MGMT mRNA and protein 
was most consistently observed and at comparatively high 
level in rat liver and rat hepatoma cells in vitro (for review 
see Ref. 1121). Thus, treatment of rat hepatoma cells with 
DNA damaging agents induced MGMT mRNA 2-5fold 
[S-11]. For rat liver, an induction was reported of up to 
lo-fold in MGMT mRNA upon treatment of animals with 
2-acetylaminofluorene [30] and up to 20-fold in MGMT 
activity upon exposure to ionizing radiation [31]. It should 
be noted that induction is not restricted to rat liver cells. It 
was also found in mouse C3HlOT1/2 cells [32] and in 
various mouse tissues [331. 
The high constitutive expression of MGMT and its 
relatively strong inducibility in rat liver cells raised the 
question whether liver-specific transcription factors are 
involved in regulation of the MGMT gene. If liver-specific 
transcription factors are involved, it would be expected 
that MGMT expression is related to the expression of the 
genes that are regulated in a liver-specific fashion. Here 
we have shown that the basal level of expression of 
MGMT mRNA and activity correlates with the amount of 
TAT mRNA and thus is related to the status of differentia- 
tion of liver cells. These results confirm and extend a 
previous report based on measurement of MGMT activity 
in rat hepatoma cell lines [20]. One could speculate that the 
induction of MGMT in rats is also related to the liver- 
specific status of differentiation since MGMT is most 
efficiently induced in liver cells. In line with this would be 
that H5 cells exhibiting the lowest degree of differentiation 
did not show detectable MGMT mRNA and protein induc- 
tion whereas the well differentiated hepatocytes elicited a 
relatively strong response after X-ray and MNNG treat- 
ment. However, for the other hepatoma cell lines, we did 
not find a clear-cut correlation between induction and the 
degree of differentiation. Thus, Fao cells which are highly 
differentiated (in terms of TAT and aldrin epoxidase ex- 
pression) and displayed a high basal level of MGMT 
mRNA showed only very weak MGMT mRNA induction. 
This indicates that a high degree of differentiation (does 
not necessarily enable the cells to respond strongly with 
MGMT induction. Induction depends on the presence of an 
inducing signal (probably DNA damage, Ref. [ll]). We 
cannot exclude the possibility that Fao cells are more 
efficient than the other cell types in eliminating the induc- 
ing signal and thus they could also be potentially respon- 
sive to induction. It is also obvious from the results 
obtained that a low basal level of MGMT mRNA and 
protein is not decisive for its induction, and that a high 
basal level, as observed in hepatocytes and various hep- 
atoma cell lines, does not prevent the gene to be further 
activated by exposure to mutagens. The increase of MGMT 
mRNA upon mutagen treatment has been concluded to be 
due to transcriptional activation of the gene since the RNA 
synthesis inhibitor actinomycin D abolished MGMT mRNA 
accumulation [8] and since MGMT induction was also 
observed in nuclear run-on assays [31]. 
We have found, in spheroid cultures of primary rat 
hepatoma cells, a maximum of induction of MGMT (on 
RNA level) by approx. 6-fold. There are several possible 
reasons why we did not observe a similar high level of 
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Fig. 8. Survival of rat hepatoma cell lines upon treatment with MNNG or MMS. For comparison the Mex - Chinese hamster cell line CHO-9 was included 
in this study. Each point represents the mean value of three independent experiments. 
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induction in hepatocytes in vitro, as compared to in vivo 
experiments [31]. 1) The hepatocytes became dedifferenti- 
ated immediately after their isolation and during their 
maintenance in culture (for up to 1 week). Thus, cy- 
tochrom P-450 and aldrin epoxidase activity was shown to 
decrease by about 40-60% in our hepatocyte spheroids at 
the end of the cultivation period [22]. 2) Maximum of 
induction in the liver was found with 15 Gy of irradiation 
[31]. We used a relatively low dose of 2 Gy since we were 
interested in studying the effect of the mutagen under 
conditions that allowed the cells to survive. Increasing the 
dose of both X-rays and MNNG enhanced induction but 
also elicited strong toxic effects (data not shown). 3) The 
hepatocytes were derived from male rats. We cannot ex- 
clude a gender effect as previously reported [31]. Neverthe- 
less, the relatively high induction level of MGMT in 
primary hepatocytes grown as spheroids make them a 
suitable experimental system for studying the regulation of 
MGMT in relation to liver-specific functions. 
All DNA damaging treatments studied so far, including 
the electroporation of restriction enzymes, gave rise to 
induction of MGMT mRNA and protein which led to the 
conclusion that DNA breaks are the ultimate signal for 
eliciting the response [7,11]. This, however, does not ex- 
clude the possibility that physiological signals can also act 
as inducers. In this context it should be noted that the 
liver-specific tumor promoter phenobarbital induced 
MGMT mRNA in hepatocytes. Phenobarbital is not a 
DNA damaging agent. It induces alterations in gene ex- 
pression in the liver [34] apparently involving MGMT as 
well. 
Previously it has been reported that the MPG repair 
activity and MPG mRNA are enhanced after mutagen 
exposure of H4 cells [9,12,35]. It should be noted, how- 
ever, that it is not clear whether MPG is inducible on the 
transcriptional level or whether post-transcriptional mecha- 
nisms, such as mRNA and protein stabilization, are in- 
volved. Here we have shown that 24 h after mutagen 
treatment, MGMT mRNA was induced in differentiated 
hepatoma cell lines and hepatocytes, but there was no 
significant induction of MPG mRNA. The MPG activity 
was assayed 48 h after mutagen exposure and was found to 
be enhanced up to 3.4-fold in only one cell line (H4IIE). 
The results are in line with our previous observation that 
MPG induction in H4IIE cells is delayed with the maxi- 
mum response occurring 48 h after mutagen exposure 
(Hartenstein and Kaina, unpublished data). Induction of 
MPG activity was related neither to the basal level of 
MPG mRNA and enzyme activity nor to the status of 
differentiation of liver cells. Thus the hepatocyte spheroid 
cultures exhibited only a very weak response. This again 
indicates that MPG and MGMT are not coregulated. Lack 
of coregulation is supported by the finding that MGMT, 
but not MPG is induced by phenobarbital, and that MPG is 
expressed quite uniformly in Mex and Mex+ human and 
rodent cell lines (unpublished data). 
A deeper insight into the molecular mechanism of 
MGMT and MPG regulation requires cloning of the pro- 
moter sequences of the genes. A human MGMT promoter 
fragment was isolated and shown to contain various regu- 
latory elements including a glucocorticoid responsive ele- 
ment [36] indicating that humoral control factors are possi- 
bly involved in MGMT regulation. It should be noted, 
however, that MGMT was not inducible by mutagen treat- 
ment in human fibroblasts and the human hepatoma cell 
line HepG2 [8]. Whether MGMT can be induced in well 
differentiated human hepatocytes is still an open question. 
Whereas MGMT exerts protection, the role of MPG for 
determining a given level of alkylating drug resistance is 
still unclear. Data obtained from transgenic cell lines indi- 
cate that both 06-methylguanine and N-methylpurines are 
cytotoxic, depending on the agent used for alkylation [37]. 
On the other hand, increased expression of MPG did not 
enhance resistance of Chinese hamster cells to alkylating 
drugs [38]. Comparing the sensitivity of various rat hep- 
atoma cell lines to alkylating agents, we found H5 exhibit- 
ing the lowest basal level of MGMT and no MGMT 
induction, to be most sensitive to MNNG. H5 cells, how- 
ever, were not sensitive to MMS indicating that MNNG- 
induced cytotoxicity is brought about mainly by 06-meth- 
ylguanine whereas for MMS, other lesions are decisive. 
This conclusion is in agreement with results obtained from 
transgenic cell lines [37]. Interestingly, Fao cells proved to 
be significantly more resistant to MMS although the level 
of MPG and MGMT was comparable to other lines, e.g., 
H411EC3/Gm cells. Possibly an unknown mechanism inde- 
pendent of MGMT and MPG is operating in these cells 
that protects them against MMS-induced toxicity. Overall, 
for MPG, no correlation was found between its expression 
and the cell killing effect of MNNG and MMS indicating 
that the MPG level is not a determinant of sensitivity of 
cells to the cytotoxic effect of alkylating drugs. 
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